Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross sectional study
Authors:
Open Access
- 25 January 2023
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 88, 104446
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health and Medical Research
- Food and Health Bureau
- Health and Medical Research Fund
- National Key Research and Development Program of China
This publication has 33 references indexed in Scilit:
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21The Lancet, 2022
- Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community OutbreakClinical Infectious Diseases, 2022
- Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccineEmerging Microbes & Infections, 2022
- Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccinationNature Medicine, 2022
- Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine RecipientsClinical Infectious Diseases, 2021
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort studyThe Lancet, 2021
- Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United KingdomNature Microbiology, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Correlates of protection against SARS-CoV-2 in rhesus macaquesNature, 2020
- High neutralizing antibody titer in intensive care unit patients with COVID-19Emerging Microbes & Infections, 2020